STAAR Surgical Co Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- STAAR Surgical Co payments for repurchase of common stock for the quarter ending 2026-01-02 was $0.00.
- STAAR Surgical Co payments for repurchase of common stock for the quarter ending 2025-09-26 was $1.98M.
- STAAR Surgical Co payments for repurchase of common stock for fiscal 2026 was $6.46M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-01-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $6.46M 10-K · filed 2026-03-03 |
| 2025-09-26 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |